New Oral Therapy Approved for Iron Deficiency in Adults
The FDA has approved Accrufer (ferric maltol; Shield Therapeutics) for the treatment of iron deficiency in adults.
The FDA has approved Accrufer (ferric maltol; Shield Therapeutics) for the treatment of iron deficiency in adults.
At a routine follow-up visit at the clinic a month prior, the patient reported consuming at least 2 bags of unpeeled lemons per day.
The analysis also showed that the more severe the anemia was at baseline, the greater the response was to treatment with regard to hemoglobin changes.
Despite its frequency, iron deficiency anemia in patients with IBD it is often overlooked in clinical settings.